Unfolding tyrosine kinase inhibitor sensitivity in chronic myeloid leukemia

Autor Perrotti, Danilo, Neviani, Paolo
Vydáno 2012

Targeting A Tumor Suppressor To Suppress Tumor Growth: News and Views on Protein Phosphatase 2A (PP2A) as a Target for Anti-cancer Therapy

Autor Perrotti, Danilo, Neviani, Paolo
Vydáno 2013

SETting OP449 into the PP2A-Activating-Drug family

Autor Neviani, Paolo, Perrotti, Danilo
Vydáno v Clin Cancer Res (2014)

A “RANning” leap with “XPOrt” into TKI resistance

Autor Rassool, Feyruz, Perrotti, Danilo
Vydáno v Blood (2015)

BCR–ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention

Autor PERROTTI, DANILO, HARB, JASON G.
Vydáno v Leuk Lymphoma (2011)

The new role of microRNAs in cancer

Autor Perrotti, Danilo, Eiring, Anna M
Vydáno v Future Oncol (2010)

From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies

Autor Ciccone, Maria, Calin, George A., Perrotti, Danilo
Vydáno v Front Oncol (2015)

Chronic myeloid leukemia: mechanisms of blastic transformation

Autor Perrotti, Danilo, Jamieson, Catriona, Goldman, John, Skorski, Tomasz
Vydáno 2010

Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity

Autor Salomoni, Paolo, Perrotti, Danilo, Martinez, Robert, Franceschi, Claudio, Calabretta, Bruno
Vydáno 1997

Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay

Autor Perrotti, Danilo, Silvestri, Giovannino, Stramucci, Lorenzo, Yu, Justine, Trotta, Rossana
Vydáno v Curr Drug Targets (2017)

Antileukemia effect of c-myc N3′→P5′ phosphoramidate antisense oligonucleotides in vivo

Autor Skorski, Tomasz, Perrotti, Danilo, Nieborowska-Skorska, Malgorzata, Gryaznov, Sergei, Calabretta, Bruno
Vydáno 1997

Chronic myeloid leukemia: the basis of treatment for tomorrow

Autor Carella, Angelo M., Goldman, John M., Martinelli, Giovanni, Melo, Junia V., Perrotti, Danilo
Vydáno 2011

Blastic transformation of p53-deficient bone marrow cells by p210(bcr/abl) tyrosine kinase

Autor Skorski, Tomasz, Nieborowska-Skorska, Malgorzata, Wlodarski, Pawel, Perrotti, Danilo, Martinez, Robert, Wasik, Mariusz A., Calabretta, Bruno
Vydáno 1996

Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis

Autor Iozzo, Renato V., Chakrani, Fatima, Perrotti, Danilo, McQuillan, David J., Skorski, Tomasz, Calabretta, Bruno, Eichstetter, Inge
Vydáno 1999

CCAAT/enhancer binding proteins alpha and epsilon cooperate with all-trans retinoic acid in therapy but differ in their antileukemic activities

Autor Lee, Young-Jin, Jones, Letetia C., Timchenko, Nikolai A., Perrotti, Danilo, Tenen, Daniel G., Kogan, Scott C.
Vydáno 2006

BCR-ABL Prevents c-Jun-Mediated and Proteasome-Dependent FUS (TLS) Proteolysis through a Protein Kinase CβII-Dependent Pathway

Autor Perrotti, Danilo, Iervolino, Angela, Cesi, Vincenzo, Cirinná, Maria, Lombardini, Silvia, Grassilli, Emanuela, Bonatti, Silvia, Claudio, Pier Paolo, Calabretta, Bruno
Vydáno 2000

hnRNP A1 Nucleocytoplasmic Shuttling Activity Is Required for Normal Myelopoiesis and BCR/ABL Leukemogenesis

Autor Iervolino, Angela, Santilli, Giorgia, Trotta, Rossana, Guerzoni, Clara, Cesi, Vincenzo, Bergamaschi, Anna, Gambacorti-Passerini, Carlo, Calabretta, Bruno, Perrotti, Danilo
Vydáno 2002

c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-activated Leukemias

Autor Muvarak, Nidal, Kelley, Shannon, Robert, Carine, Baer, Maria R., Perrotti, Danilo, Gambacorti-Passerini, Carlo, Civin, Curt, Scheibner, Kara, Rassool, Feyruz
Vydáno v Mol Cancer Res (2015)

Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stress

Autor Doshi, Kshama A., Trotta, Rossana, Natarajan, Karthika, Rassool, Feyruz V., Tron, Adriana E., Huszar, Dennis, Perrotti, Danilo, Baer, Maria R.
Vydáno v Oncotarget (2016)

Comment on “PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia”

Autor Perrotti, Danilo, Agarwal, Anupriya, Lucas, Claire M., Narla, Goutham, Neviani, Paolo, Odero, Maria D., Ruvolo, Peter P., Verrills, Nicole M.
Vydáno v Sci Transl Med (2019)